SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (1876)6/26/1998 3:28:00 PM
From: Profiteer  Read Replies (1) | Respond to of 5402
 
Andrew H: I suggest you call Dr. Drees yourself and report back to all of us. You seem to be hung up on precise usage of terms and language.

I'm sure everyone would be happy to receive your "exact transcript" of the conversation. (Maybe a tape recorder will help!) Thanks



To: Andrew H who wrote (1876)6/26/1998 5:49:00 PM
From: Prospector  Read Replies (1) | Respond to of 5402
 
Profiteer

don't boil over.... Iv'e talked to the Dr.. several times, he doesnt get to detailed. unless you ask him specific questions.. you and I ar'nt that familar with blood properties, FDA trails what's important and what isn't,, to know what to ask him and what not..

You kinda feel preveliged just to get to talk to him. and ya forget what yer even thinkin,, kinda like a young girl at a Beatles concert .. years ago...

So don't let Andrew Brother ya ,, he just wants to know what's going on and the questions he is askin you can ask the Dr next time.. to get a little more detail.. He's just tryin to help....

So Andrew don't get affended.. and Profiteer ...cool off.. Let's work as a team..

Andrew maybe that's not a bad Idea to call Dr Drees.. You seem to be a little more knowlegdable or how the hell ya spellit than most..

Prospector



To: Andrew H who wrote (1876)6/27/1998 12:24:00 AM
From: drdan  Read Replies (2) | Respond to of 5402
 
page 4 of the business plan states that the first application will be for the use of heart-bypass machines.Projected revenue suggested as $80million dollars based on 25% penetrance of the 300, 000 open-heart cases in US/year over three yrs.Timetable for further applications has not been laid out in the business plan, but perhaps Dr. Drees can tell us ....